227 related articles for article (PubMed ID: 30262913)
1. High-resolution NMR studies of antibiotics in cellular membranes.
Medeiros-Silva J; Jekhmane S; Paioni AL; Gawarecka K; Baldus M; Swiezewska E; Breukink E; Weingarth M
Nat Commun; 2018 Sep; 9(1):3963. PubMed ID: 30262913
[TBL] [Abstract][Full Text] [Related]
2. Towards the Native Binding Modes of Antibiotics that Target Lipid II.
Medeiros-Silva J; Jekhmane S; Breukink E; Weingarth M
Chembiochem; 2019 Jul; 20(14):1731-1738. PubMed ID: 30725496
[TBL] [Abstract][Full Text] [Related]
3. The lantibiotic nisin, a special case or not?
Breukink E; de Kruijff B
Biochim Biophys Acta; 1999 Dec; 1462(1-2):223-34. PubMed ID: 10590310
[TBL] [Abstract][Full Text] [Related]
4. Targeting extracellular pyrophosphates underpins the high selectivity of nisin.
Bonev BB; Breukink E; Swiezewska E; De Kruijff B; Watts A
FASEB J; 2004 Dec; 18(15):1862-9. PubMed ID: 15576489
[TBL] [Abstract][Full Text] [Related]
5. Mapping the targeted membrane pore formation mechanism by solution NMR: the nisin Z and lipid II interaction in SDS micelles.
Hsu ST; Breukink E; de Kruijff B; Kaptein R; Bonvin AM; van Nuland NA
Biochemistry; 2002 Jun; 41(24):7670-6. PubMed ID: 12056898
[TBL] [Abstract][Full Text] [Related]
6. In Bacterial Membranes Lipid II Changes the Stability of Pores Formed by the Antimicrobial Peptide Nisin.
Sheridan MS; Pandey P; Hansmann UHE
J Phys Chem B; 2024 May; 128(19):4741-4750. PubMed ID: 38696215
[TBL] [Abstract][Full Text] [Related]
7. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.
Breukink E; Wiedemann I; van Kraaij C; Kuipers OP; Sahl HG; de Kruijff B
Science; 1999 Dec; 286(5448):2361-4. PubMed ID: 10600751
[TBL] [Abstract][Full Text] [Related]
8. Environmental and dynamic effects explain how nisin captures membrane-bound lipid II.
Panina I; Krylov N; Nolde D; Efremov R; Chugunov A
Sci Rep; 2020 Jun; 10(1):8821. PubMed ID: 32483218
[TBL] [Abstract][Full Text] [Related]
9. Computational study of nisin interaction with model membrane.
Lins L; Ducarme P; Breukink E; Brasseur R
Biochim Biophys Acta; 1999 Aug; 1420(1-2):111-20. PubMed ID: 10446296
[TBL] [Abstract][Full Text] [Related]
10. Structural dynamics of the cell wall precursor lipid II in the presence and absence of the lantibiotic nisin.
Koch DC; Schmidt TH; Sahl HG; Kubitscheck U; Kandt C
Biochim Biophys Acta; 2014 Dec; 1838(12):3061-8. PubMed ID: 25128154
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional structure of the lantibiotic nisin in the presence of membrane-mimetic micelles of dodecylphosphocholine and of sodium dodecylsulphate.
Van Den Hooven HW; Doeland CC; Van De Kamp M; Konings RN; Hilbers CW; Van De Ven FJ
Eur J Biochem; 1996 Jan; 235(1-2):382-93. PubMed ID: 8631358
[TBL] [Abstract][Full Text] [Related]
12. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the lantibiotic nisin with membranes revealed by fluorescence quenching of an introduced tryptophan.
Martin I; Ruysschaert JM; Sanders D; Giffard CJ
Eur J Biochem; 1996 Jul; 239(1):156-64. PubMed ID: 8706701
[TBL] [Abstract][Full Text] [Related]
14. Interaction of the lantibiotic nisin with mixed lipid bilayers: a 31P and 2H NMR study.
Bonev BB; Chan WC; Bycroft BW; Roberts GC; Watts A
Biochemistry; 2000 Sep; 39(37):11425-33. PubMed ID: 10985788
[TBL] [Abstract][Full Text] [Related]
15. New Insights into Nisin's Antibacterial Mechanism Revealed by Binding Studies with Synthetic Lipid II Analogues.
't Hart P; Oppedijk SF; Breukink E; Martin NI
Biochemistry; 2016 Jan; 55(1):232-7. PubMed ID: 26653142
[TBL] [Abstract][Full Text] [Related]
16. Bioengineering nisin to overcome the nisin resistance protein.
Field D; Blake T; Mathur H; O' Connor PM; Cotter PD; Paul Ross R; Hill C
Mol Microbiol; 2019 Mar; 111(3):717-731. PubMed ID: 30537404
[TBL] [Abstract][Full Text] [Related]
17. Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.
Li Q; Montalban-Lopez M; Kuipers OP
Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625984
[TBL] [Abstract][Full Text] [Related]
18. Interactions of the antimicrobial peptide nisin Z with conventional antibiotics and the use of nanostructured lipid carriers to enhance antimicrobial activity.
Lewies A; Wentzel JF; Jordaan A; Bezuidenhout C; Du Plessis LH
Int J Pharm; 2017 Jun; 526(1-2):244-253. PubMed ID: 28461263
[TBL] [Abstract][Full Text] [Related]
19. Structural features of the final intermediate in the biosynthesis of the lantibiotic nisin. Influence of the leader peptide.
van den Hooven HW; Rollema HS; Siezen RJ; Hilbers CW; Kuipers OP
Biochemistry; 1997 Nov; 36(46):14137-45. PubMed ID: 9369486
[TBL] [Abstract][Full Text] [Related]
20. Nisin Z, mutant nisin Z and lacticin 481 interactions with anionic lipids correlate with antimicrobial activity. A monolayer study.
Demel RA; Peelen T; Siezen RJ; De Kruijff B; Kuipers OP
Eur J Biochem; 1996 Jan; 235(1-2):267-74. PubMed ID: 8631341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
